# Bioanalytical Systems, Inc. (BASI)

Source: https://www.quantisnow.com/company/BASI
Generated: 2026-11-09T21:36:26.945Z

- Ticker: BASI
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Commercial Physical & Biological Resarch
- IPO year: 1997

## Latest BASI news and filings

- 2022-11-03 18:09 UTC [SEC Form RW filed by Bioanalytical Systems, Inc.](https://www.quantisnow.com/insight/sec-form-rw-filed-by-bioanalytical-systems-inc-3627467)
- 2021-03-19 20:30 UTC [SEC Form 8-K] [SEC Form 8-K filed by Bioanalytical Systems, Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-bioanalytical-systems-inc-532192)
- 2021-03-19 20:05 UTC [Bioanalytical Systems, Inc. Announces Corporate Name Change to Inotiv, Inc.](https://www.quantisnow.com/insight/bioanalytical-systems-inc-announces-corporate-name-change-to-inotiv-inc-531898)
- 2021-03-17 12:33 UTC [Bioanalytical Systems, Inc., doing business as Inotiv, Announces Plan to Expand Service Offerings to Include Cardiovascular Safety Pharmacology](https://www.quantisnow.com/insight/bioanalytical-systems-inc-doing-business-as-inotiv-announces-plan-to-520902)
- 2021-03-09 13:33 UTC [Bioanalytical Systems, Inc., doing business as Inotiv, Invests in Additional Vivarium Capacity at Facility in West Lafayette, IN](https://www.quantisnow.com/insight/bioanalytical-systems-inc-doing-business-as-inotiv-invests-in-additional-488058)
- 2021-03-09 11:06 UTC [SEC Form 8-K filed](https://www.quantisnow.com/insight/sec-form-8-k-filed-486779)
- 2021-03-09 09:15 UTC [Analyst Coverage Resumed] [Colliers Securities resumed coverage on Bioanalytical Systems with a new price target](https://www.quantisnow.com/insight/colliers-securities-resumed-coverage-on-bioanalytical-systems-with-a-new-486464)
- 2021-03-05 21:41 UTC [SEC Form 4] [SEC Form 4: Beth Taylor bought $88,500 worth of Common Shares (5,000 units at $17.70), increasing direct ownership by 17% to 34,295 units](https://www.quantisnow.com/insight/sec-form-4-beth-taylor-bought-88500-worth-of-common-479138)
- 2021-03-04 13:33 UTC [Conference Announcement] [Bioanalytical Systems, Inc., doing business as Inotiv, to Participate in the H.C. Wainwright Global Life Sciences Virtual Conference](https://www.quantisnow.com/insight/bioanalytical-systems-inc-doing-business-as-inotiv-to-participate-in-472083)
- 2021-03-02 05:15 UTC [SEC Form EFFECT filed](https://www.quantisnow.com/insight/sec-form-effect-filed-456344)
- 2021-03-01 21:14 UTC [SEC Form 4] [SEC Form 4: Gregory John Beattie bought $31,843 worth of Common Shares (1,712 units at $18.60), increasing ownership by 7% to 25,000 units](https://www.quantisnow.com/insight/sec-form-4-gregory-john-beattie-bought-31843-worth-of-453642)
- 2021-02-25 21:03 UTC [SEC Form 4] [SEC Form 4: Gregory John Beattie bought $116,032 worth of Common Shares (8,288 units at $14.00), increasing ownership by 55% to 23,288 units](https://www.quantisnow.com/insight/sec-form-4-gregory-john-beattie-bought-116032-worth-of-441410)
- 2021-02-24 21:29 UTC [SEC Form 4] [SEC Form 4: Jr. Robert Leasure bought $72,100 worth of Common Shares (5,000 units at $14.42)](https://www.quantisnow.com/insight/sec-form-4-jr-robert-leasure-bought-72100-worth-of-429335)
- 2021-02-24 13:33 UTC [Bioanalytical Systems, Inc., doing business as Inotiv, Invests in Laboratory Infrastructure and Data and Study Management Technologies](https://www.quantisnow.com/insight/bioanalytical-systems-inc-doing-business-as-inotiv-invests-in-laboratory-427165)
- 2021-02-19 21:45 UTC [SEC Form S-3 filed](https://www.quantisnow.com/insight/sec-form-s-3-filed-415443)
- 2021-02-16 21:01 UTC [SEC Form 3] [SEC Form 3 filed by Gregory John Beattie](https://www.quantisnow.com/insight/sec-form-3-filed-by-gregory-john-beattie-401676)
- 2021-02-16 20:42 UTC [SEC Schedule 13G] [SEC Form SC 13G filed](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-401257)
- 2021-02-11 21:05 UTC [Leadership Update] [Bioanalytical Systems, Inc., doing business as Inotiv, Appoints Greg Beattie as Chief Operating Officer](https://www.quantisnow.com/insight/bioanalytical-systems-inc-doing-business-as-inotiv-appoints-greg-beattie-384721)
- 2021-02-10 21:31 UTC [SEC Form 10-Q filed](https://www.quantisnow.com/insight/sec-form-10-q-filed-378842)
- 2021-02-10 14:57 UTC [SEC Schedule 13G] [SEC Form SC 13G filed](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-374394)
- 2021-02-09 21:10 UTC [SEC Form 8-K filed](https://www.quantisnow.com/insight/sec-form-8-k-filed-370218)
- 2021-02-09 21:05 UTC [Bioanalytical Systems, Inc., Announces First Quarter Fiscal 2021 Financial Results](https://www.quantisnow.com/insight/bioanalytical-systems-inc-announces-first-quarter-fiscal-2021-financial-results-370085)
- 2021-02-03 18:35 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-347980)
- 2021-01-28 22:00 UTC [SEC Form DEFA14A filed](https://www.quantisnow.com/insight/sec-form-defa14a-filed-327239)
- 2021-01-28 21:55 UTC [SEC Form DEF 14A filed](https://www.quantisnow.com/insight/sec-form-def-14a-filed-327176)
- 2021-01-26 13:33 UTC [Bioanalytical Systems, Inc., to Report First Quarter Fiscal 2021 Financial Results and Host Conference Call on Tuesday, February 9, 2021](https://www.quantisnow.com/insight/bioanalytical-systems-inc-to-report-first-quarter-fiscal-2021-financial-314488)
- 2021-01-19 13:33 UTC [Inotiv Broadens Pathology Service Offerings](https://www.quantisnow.com/insight/inotiv-broadens-pathology-service-offerings-293138)
- 2021-01-15 21:30 UTC [SEC Form PRE 14A filed](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-289293)
- 2021-01-12 21:41 UTC [SEC Form 4: Matthew R Neff bought $45,789 worth of Common Shares (11,847 units at $3.87), increasing ownership by 38% to 43,430 units](https://www.quantisnow.com/insight/sec-form-4-matthew-r-neff-bought-45789-worth-of-278782)
- 2021-01-12 21:34 UTC [SEC Form 4: Matthew R Neff bought $43,507 worth of Common Shares (9,458 units at $4.60), increasing ownership by 43% to 31,583 units](https://www.quantisnow.com/insight/sec-form-4-matthew-r-neff-bought-43507-worth-of-278742)
- 2021-01-11 13:33 UTC [Daniel Smeak, DVM, ACVS, Joins Inotiv as Vice President, Surgical Models](https://www.quantisnow.com/insight/daniel-smeak-dvm-acvs-joins-inotiv-as-vice-president-surgical-272200)
- 2021-01-04 22:00 UTC [SEC Form 8-K filed](https://www.quantisnow.com/insight/sec-form-8-k-filed-251729)
- 2020-12-30 21:05 UTC [SEC Form 4 filed](https://www.quantisnow.com/insight/sec-form-4-filed-245463)
- 2020-12-22 22:21 UTC [SEC Form 1 filed](https://www.quantisnow.com/insight/sec-form-1-filed-234769)
- 2020-12-21 22:18 UTC [SEC Form 8 filed](https://www.quantisnow.com/insight/sec-form-8-filed-231214)
- 2020-12-21 13:33 UTC [Conference Announcement] [BASi Releases Earnings for Fourth Quarter of Fiscal 2020](https://www.quantisnow.com/insight/basi-releases-earnings-for-fourth-quarter-of-fiscal-2020-229030)
- 2020-12-18 22:00 UTC [BASi to Release Earnings for Fourth Quarter of Fiscal 2020 on Monday, December 21, 2020](https://www.quantisnow.com/insight/basi-to-release-earnings-for-fourth-quarter-of-fiscal-2020-226847)
- 2020-10-20 12:33 UTC [Andrew N. Alexander, DVM, Ph.D., MBA, DABT, Joins Inotiv as Vice President, Pharmacology and Toxicology Operations](https://www.quantisnow.com/insight/andrew-n-alexander-dvm-phd-mba-dabt-joins-inotiv-as-108241)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/BASI
- Earnings history: https://www.quantisnow.com/earnings/BASI
- Dividend history: https://www.quantisnow.com/dividends/BASI
- Insider transactions: https://www.quantisnow.com/insiders/BASI
- Options chain: https://www.quantisnow.com/options/BASI
- SEC 8-K filings only: https://www.quantisnow.com/company/BASI/8-k
- RSS and alerts for BASI: https://www.quantisnow.com/docs/rss-feeds.md